OBJECTIVE: 20-Hydroxyeicosatetraenoic acid has been shown to play an important role in cerebral vascular function. We hypothesized that polymorphisms in genes encoding 20-Hydroxyeicosatetraenoic acid synthesizing enzymes might confer susceptibility to stroke. METHODS AND RESULTS: To test the hypothesis, haplotype tagging single nucleotide polymorphisms and potential functional polymorphisms of CYP4A11 and CYP4F2 genes were genotyped in 558 ischemic stroke patients, 221 hemorrhagic stroke patients and 557 controls. The association analyses were performed at both single nucleotide polymorphism and haplotype levels. We further verified our findings in an independent cohort of 551 ischemic stroke cases and 48 hemorrhagic stroke cases and 694 unaffected controls. We identified CYP4A11 C-296T and CYP4F2 V433M were associated with significantly increased risk of ischemic stroke (CT+TT vs. CC, adjusted odds ratio: 1.50, 95% confidence interval: 1.17-1.93, Pcombined=0.001, Pcorr=0.008; V/M+M/M vs. V/V, odds ratio: 1.38, 95% confidence interval: 1.15-1.65, Pcombined=5.6x10, Pcorr=0.005, respectively). Interestingly, the effects of CYP4F2 V433M on ischemic stroke in our study was only evident in male individuals. CONCLUSION: Our results suggest that genetic variation in CYP4A11 and CYP4F2 alters susceptibility to stroke in the Han Chinese population.
OBJECTIVE:20-Hydroxyeicosatetraenoic acid has been shown to play an important role in cerebral vascular function. We hypothesized that polymorphisms in genes encoding 20-Hydroxyeicosatetraenoic acid synthesizing enzymes might confer susceptibility to stroke. METHODS AND RESULTS: To test the hypothesis, haplotype tagging single nucleotide polymorphisms and potential functional polymorphisms of CYP4A11 and CYP4F2 genes were genotyped in 558 ischemic strokepatients, 221 hemorrhagic strokepatients and 557 controls. The association analyses were performed at both single nucleotide polymorphism and haplotype levels. We further verified our findings in an independent cohort of 551 ischemic stroke cases and 48 hemorrhagic stroke cases and 694 unaffected controls. We identified CYP4A11C-296T and CYP4F2V433M were associated with significantly increased risk of ischemic stroke (CT+TT vs. CC, adjusted odds ratio: 1.50, 95% confidence interval: 1.17-1.93, Pcombined=0.001, Pcorr=0.008; V/M+M/M vs. V/V, odds ratio: 1.38, 95% confidence interval: 1.15-1.65, Pcombined=5.6x10, Pcorr=0.005, respectively). Interestingly, the effects of CYP4F2V433M on ischemic stroke in our study was only evident in male individuals. CONCLUSION: Our results suggest that genetic variation in CYP4A11 and CYP4F2 alters susceptibility to stroke in the Han Chinese population.
Authors: Cristiano Fava; Martina Montagnana; Peter Almgren; Lena Rosberg; Giuseppe Lippi; Bo Hedblad; Gunnar Engström; Göran Berglund; Pietro Minuz; Olle Melander Journal: Hypertension Date: 2008-06-23 Impact factor: 10.190
Authors: Jennifer Cheng; Jing-Song Ou; Harpreet Singh; John R Falck; Dubasi Narsimhaswamy; Kirkwood A Pritchard; Michal Laniado Schwartzman Journal: Am J Physiol Heart Circ Physiol Date: 2007-12-21 Impact factor: 4.733
Authors: Ji-Shi Wang; Harpreet Singh; Frank Zhang; Tsuneo Ishizuka; Huan Deng; Rowena Kemp; Michael S Wolin; Thomas H Hintze; Nader G Abraham; Alberto Nasjletti; Michal Laniado-Schwartzman Journal: Circ Res Date: 2006-03-16 Impact factor: 17.367
Authors: Tsuneo Ishizuka; Jennifer Cheng; Harpreet Singh; Marco D Vitto; Vijay L Manthati; John R Falck; Michal Laniado-Schwartzman Journal: J Pharmacol Exp Ther Date: 2007-10-18 Impact factor: 4.030
Authors: Natalie C Ward; I-Jung Tsai; Anne Barden; Frank M van Bockxmeer; Ian B Puddey; Jonathan M Hodgson; Kevin D Croft Journal: Hypertension Date: 2008-04-07 Impact factor: 10.190
Authors: Albert W Dreisbach; Stanley V Smith; Patrick B Kyle; Manjunath Ramaiah; Margaret Amenuke; Michael R Garrett; Seth T Lirette; Michael E Griswold; Richard J Roman Journal: Prostaglandins Other Lipid Mediat Date: 2014-08-22 Impact factor: 3.072